Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | RARB | P10826 | 1/20 | 0.35 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.35 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.35 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.34 |
| ▸ | BRS3 | P32247 | 1/20 | 0.34 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.33 |
| ▸ | XDH | P47989 | 1/20 | 0.33 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.33 |
| ▸ | CEL | P19835 | 1/20 | 0.33 |
| ▸ | MOGAT2 | Q3SYC2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8767859 | 0.99 | RARB (0.37) | TDP1RARBPDGFRBPDGFRASPHK1 | |
| SCHEMBL8767155 | 0.99 | RARB (0.37) | TDP1RARBPDGFRBPDGFRASPHK1 | |
| SCHEMBL8768327 | 0.99 | RARB (0.37) | TDP1RARBPDGFRBPDGFRASPHK1 | |
| SCHEMBL8768454 | 0.86 | XDH (0.45) | XDH | |
| SCHEMBL8767203 | 0.85 | RAB9A (0.46) | TDP1GRM2 | |
| SCHEMBL8768280 | 0.85 | XDH (0.44) | XDH | |
| SCHEMBL8768299 | 0.85 | XDH (0.44) | XDH | |
| SCHEMBL9649673 | 0.84 | RARB (0.41) | RARBPDGFRBPDGFRAGRIN2BGRM2 | |
| SCHEMBL9649663 | 0.84 | RARB (0.41) | RARBPDGFRBPDGFRAGRIN2BGRM2 | |
| SCHEMBL9648727 | 0.83 | RARB (0.43) | RARBPDGFRBPDGFRAGRIN2BGRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0789067-A1 | Cyclopentyl derivatives useful as liquid crystals | Rolic AG (CH) | 1997-08-13 | — | — | EP | disclosed |